MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Altamira Therapeutics Ltd. (NASDAQ: CYTO)*
Organization & Developments: Altamira Therapeutics
Parents
Altamira Therapeutics Ltd. (NASDAQ: CYTO)*
Children
2022: Uses cell-penetrating peptides for mRNA delivery to cancer cells based on uptake and transfection capacity of Altamira's proprietary delivery platform, SemaPhore.
2024: Altamira Therapeutics Ltd. 2023 Q4 - Results - Earnings Call Presentation
Jumps
Finance & Acquisitions: Altamira Therapeutics
Key People: Altamira Therapeutics